Edge Therapeutics, Inc. (29) | Uncategorized (7)

Recent Contracts

PDS Biotechnology Corporation 2019 Inducement Plan, as amended (Filed With SEC on May 18, 2022)
Option Agreement with University of Georgia Research Foundation, Inc. effective as of October 25, 2021 (Filed With SEC on March 31, 2022)
PDS Biotechnology Corporation 2019 Inducement Plan, as amended (Filed With SEC on December 9, 2020)
Description of Securities (Filed With SEC on March 27, 2020)
Offer Letter, dated February 1, 2019, by and between PDS Biotechnology Corporation and Lauren V. Wood, M.D (Filed With SEC on August 1, 2019)
PDS Biotechnology Corporation 2019 Inducement Plan (Filed With SEC on June 20, 2019)
Letter Agreement, dated as of February 3, 2019, by and among Edge Therapeutics, Inc., PDS Biotechnology Corporation and Brian A. Leuthner (Filed With SEC on February 4, 2019)